SG11202006215TA - Peptide immunogens and formulations thereof targeting membrane-bound ige for treatment of ige mediated allergic diseases - Google Patents
Peptide immunogens and formulations thereof targeting membrane-bound ige for treatment of ige mediated allergic diseasesInfo
- Publication number
- SG11202006215TA SG11202006215TA SG11202006215TA SG11202006215TA SG11202006215TA SG 11202006215T A SG11202006215T A SG 11202006215TA SG 11202006215T A SG11202006215T A SG 11202006215TA SG 11202006215T A SG11202006215T A SG 11202006215TA SG 11202006215T A SG11202006215T A SG 11202006215TA
- Authority
- SG
- Singapore
- Prior art keywords
- ige
- formulations
- treatment
- allergic diseases
- peptide immunogens
- Prior art date
Links
- 208000026935 allergic disease Diseases 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 230000001404 mediated effect Effects 0.000 title 1
- 239000012528 membrane Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 230000008685 targeting Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
- C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2017/069174 WO2019133024A1 (en) | 2017-12-31 | 2017-12-31 | Peptide immunogens and formulations thereof targeting membrane-bound ige for treatment of ige mediated allergic diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202006215TA true SG11202006215TA (en) | 2020-07-29 |
Family
ID=67068075
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202006215TA SG11202006215TA (en) | 2017-12-31 | 2017-12-31 | Peptide immunogens and formulations thereof targeting membrane-bound ige for treatment of ige mediated allergic diseases |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230270848A1 (en) |
| EP (1) | EP3731934A1 (en) |
| JP (1) | JP7239203B2 (en) |
| KR (2) | KR20240110105A (en) |
| CN (1) | CN111565801B (en) |
| AU (1) | AU2017445171A1 (en) |
| BR (1) | BR112020013352A2 (en) |
| CA (1) | CA3087036A1 (en) |
| MX (1) | MX2020006937A (en) |
| RU (1) | RU2769983C2 (en) |
| SG (1) | SG11202006215TA (en) |
| TW (1) | TWI804553B (en) |
| WO (1) | WO2019133024A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230146694A1 (en) * | 2020-01-23 | 2023-05-11 | United Biomedical, Inc. | Peptide immunogens targeting pituitary adenylate cyclase-activating peptide (pacap) and formulations thereof for prevention and treatment of migraine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0787150A1 (en) * | 1994-10-25 | 1997-08-06 | United Biomedical, Inc. | SYNTHETIC IgE MEMBRANE ANCHOR PEPTIDE IMMUNOGENS FOR THE TREATMENT OF ALLERGY |
| TWI227241B (en) * | 1998-06-20 | 2005-02-01 | United Biomedical Inc | IgE-CH3 domain antigen peptide, peptide conjugate containing the same, and pharmaceutical composition for treating allergies containing the peptide conjugate |
| EP1330263A2 (en) * | 2000-09-06 | 2003-07-30 | Pharmexa A/S | Method for down-regulating ige |
| US6906169B2 (en) * | 2001-05-25 | 2005-06-14 | United Biomedical, Inc. | Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide |
| US20060052592A1 (en) * | 2002-06-20 | 2006-03-09 | Levinson Arnold I | Vaccines for suppressing ige-mediated allergic disease and methods for using the same |
| WO2010097012A1 (en) * | 2009-02-25 | 2010-09-02 | Tsewen Chang | ANTI-CεmX ANTIBODIES CAPABLE OF BINDING TO HUMAN mIgE ON B LYMPHOCYTES |
| US9102752B2 (en) * | 2013-03-15 | 2015-08-11 | United Biomedical, Inc. | Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type |
-
2017
- 2017-12-31 RU RU2020125383A patent/RU2769983C2/en active
- 2017-12-31 SG SG11202006215TA patent/SG11202006215TA/en unknown
- 2017-12-31 WO PCT/US2017/069174 patent/WO2019133024A1/en active Application Filing
- 2017-12-31 KR KR1020247022412A patent/KR20240110105A/en active Search and Examination
- 2017-12-31 BR BR112020013352-3A patent/BR112020013352A2/en active Search and Examination
- 2017-12-31 CN CN201780098083.4A patent/CN111565801B/en active Active
- 2017-12-31 MX MX2020006937A patent/MX2020006937A/en unknown
- 2017-12-31 AU AU2017445171A patent/AU2017445171A1/en active Pending
- 2017-12-31 EP EP17936219.9A patent/EP3731934A1/en not_active Withdrawn
- 2017-12-31 KR KR1020207022271A patent/KR20200115522A/en not_active Application Discontinuation
- 2017-12-31 CA CA3087036A patent/CA3087036A1/en active Pending
- 2017-12-31 US US16/959,378 patent/US20230270848A1/en active Pending
- 2017-12-31 JP JP2020536658A patent/JP7239203B2/en active Active
-
2018
- 2018-12-26 TW TW107147187A patent/TWI804553B/en active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20200115522A (en) | 2020-10-07 |
| CA3087036A1 (en) | 2019-07-04 |
| WO2019133024A1 (en) | 2019-07-04 |
| US20230270848A1 (en) | 2023-08-31 |
| JP7239203B2 (en) | 2023-03-14 |
| RU2020125383A3 (en) | 2022-01-31 |
| JP2021515744A (en) | 2021-06-24 |
| EP3731934A1 (en) | 2020-11-04 |
| CN111565801A (en) | 2020-08-21 |
| AU2017445171A1 (en) | 2020-08-13 |
| KR20240110105A (en) | 2024-07-12 |
| TWI804553B (en) | 2023-06-11 |
| RU2769983C2 (en) | 2022-04-12 |
| RU2020125383A (en) | 2022-01-31 |
| BR112020013352A2 (en) | 2020-12-01 |
| MX2020006937A (en) | 2020-10-05 |
| TW201930346A (en) | 2019-08-01 |
| CN111565801B (en) | 2023-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262608A (en) | Combination treatment of ocular inflammatory disorders and diseases | |
| PL3349783T3 (en) | Compositions and methods relating to the treatment of diseases | |
| HK1246712A1 (en) | Nerve stimulation for treatment of diseases and disorders | |
| IL267210A (en) | Amino acid compositions and methods for the treatment of muscle diseases and disorders | |
| IL271274A (en) | Methods and compositions for the activation of tumor cytotoxicity via human gamma-delta t-cells | |
| ZA201908616B (en) | Formulations for treatment of post-traumatic stress disorder | |
| IL269901B (en) | Pharmaceutical compositions and methods of treating cardiovascular diseases | |
| ZA201903003B (en) | Treatment of neurological diseases | |
| IL264070A (en) | Methods and compositions for treatment of disorders and diseases involving rdh12 | |
| EP3713553A4 (en) | Compositions and methods for treatment of eye diseases | |
| IL259710A (en) | Compositions and methods of treatment for mvid and related diseases | |
| PT3200828T (en) | Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders | |
| EP3468540A4 (en) | Pharmaceutical compositions and methods for treatment of pain | |
| EP3606522C0 (en) | Novel treatment of mitochondrial diseases | |
| SG11202006215TA (en) | Peptide immunogens and formulations thereof targeting membrane-bound ige for treatment of ige mediated allergic diseases | |
| PL3515409T3 (en) | Complex and compositions for the treatment of ophthalmic and dermatological diseases | |
| EP3402511A4 (en) | Compositions and methods for treatment of ocular diseases | |
| EP3534932A4 (en) | Treatment of diseases related to igfb3 and its receptor | |
| EP3500591A4 (en) | Compositions and methods for treatment of bone associated diseases | |
| GB201714303D0 (en) | Treatment of neurodegenerative diseases | |
| GB201714311D0 (en) | Treatment of neurodegenerative diseases | |
| KR20180085033A (en) | PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF SKIN DISEASES | |
| EP3328428A4 (en) | Methods and compositions for the treatment of immunomodulatory diseases and disorders | |
| EP3335141A4 (en) | Personalized treatment of diseases and disorders | |
| GB201706662D0 (en) | Treatment of neurological diseases |